These data suggest that the interaction of specific tumor-associated ligands [24] could induce the expansion of different KIR+ CD8+ T cell subsets that decisively contribute to the metastatic dispersion of the tumor and the outcome of the patient. Here, KIR3DL1 is linked to neoplasm.